Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioElectronics Corporation (BIEL)
OTHER OTC:BIEL
Holding BIEL?
Track your performance easily
BIEL Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
BIEL FAQ
What was BioElectronics Corporation’s price range in the past 12 months?
Currently, no data Available
What is BioElectronics Corporation’s market cap?
Currently, no data Available
When is BioElectronics Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioElectronics Corporation’s earnings last quarter?
Currently, no data Available
Is BioElectronics Corporation overvalued?
According to Wall Street analysts BioElectronics Corporation’s price is currently Overvalued.
Does BioElectronics Corporation pay dividends?
BioElectronics Corporation does not currently pay dividends.
What is BioElectronics Corporation’s EPS estimate?
BioElectronics Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioElectronics Corporation have?
BioElectronics Corporation has 18,076,402,000 shares outstanding.
What happened to BioElectronics Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BioElectronics Corporation?
Currently, no hedge funds are holding shares in BIEL
---
Company Description
BioElectronics Corporation
BioElectronics Corp. engages in the development of wearable, nueromodulation devices for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications. Its products include ActiPatch, Allay, Smart Insole, HealFast, and RecoveryRx. The company was founded by Andrew J. Whelan on April 10, 2000 and is headquartered in Frederick, MD.
---
---